Clinical Trials Directory

Trials / Completed

CompletedNCT03272295

A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients

A Randomised, Controlled, Double-Blind Study to Examine Nicotine Pharmacokinetics and Smoking Behaviour in Healthy Smokers When Smoking Cigarettes Containing Different Commonly Used Ingredients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
British American Tobacco (Investments) Limited · Industry
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study will compare nicotine delivery and smoking behaviour in healthy subjects using several combustible cigarette prototypes containing different ingredients which are commonly used in the European Union.

Conditions

Interventions

TypeNameDescription
OTHERReference cigaretteThe reference product is based on a commercially-available king-size cigarette design (length 83 mm, circumference 24.6 mm) with a single segment cellulose acetate filter and tobacco blend recipe without ingredients.
OTHERCigarette with carob bean extractBased on reference cigarette with added ingredient
OTHERCigarette with cocoa powderBased on reference cigarette with added ingredient
OTHERCigarette with fenugreek extractBased on reference cigarette with added ingredient
OTHERCigarette with fig juiceBased on reference cigarette with added ingredient
OTHERCigarette with glycerolBased on reference cigarette with added ingredient
OTHERCigarette with guaiacolBased on reference cigarette with added ingredient
OTHERCigarette with liquorice extract powderBased on reference cigarette with added ingredient
OTHERCigarette plus I-mentholBased on reference cigarette with added ingredient
OTHERCigarette with propylene glycolBased on reference cigarette with added ingredient
OTHERCigarette with sorbitolBased on reference cigarette with added ingredient
OTHERCigarette with multiple ingredientsBased on reference cigarette plus propylene glycol, glycerol, liquorice extract powder, cocoa powder, carob bean extract, fig juice concentrate, maltol, guaiacol, geraniol, fenugreek extract.

Timeline

Start date
2017-09-12
Primary completion
2017-12-08
Completion
2017-12-08
First posted
2017-09-05
Last updated
2022-12-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03272295. Inclusion in this directory is not an endorsement.